BR112018077397A2 - diprovocims: uma classe de agonistas de tlr - Google Patents
diprovocims: uma classe de agonistas de tlrInfo
- Publication number
- BR112018077397A2 BR112018077397A2 BR112018077397A BR112018077397A BR112018077397A2 BR 112018077397 A2 BR112018077397 A2 BR 112018077397A2 BR 112018077397 A BR112018077397 A BR 112018077397A BR 112018077397 A BR112018077397 A BR 112018077397A BR 112018077397 A2 BR112018077397 A2 BR 112018077397A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- diprovocin
- diprovocim
- tlr agonists
- agonists
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 4
- ABZBNXFGYUSVCJ-UYMKNZQYSA-N (3S,4S)-1-[4-[(3S,4S)-3,4-bis[[(1S,2R)-2-phenylcyclopropyl]carbamoyl]pyrrolidine-1-carbonyl]benzoyl]-3-N,4-N-bis[(1S,2R)-2-phenylcyclopropyl]pyrrolidine-3,4-dicarboxamide Chemical compound O=C(N[C@H]1C[C@@H]1c1ccccc1)[C@@H]1CN(C[C@H]1C(=O)N[C@H]1C[C@@H]1c1ccccc1)C(=O)c1ccc(cc1)C(=O)N1C[C@H]([C@@H](C1)C(=O)N[C@H]1C[C@@H]1c1ccccc1)C(=O)N[C@H]1C[C@@H]1c1ccccc1 ABZBNXFGYUSVCJ-UYMKNZQYSA-N 0.000 abstract 1
- 102000004895 Lipoproteins Human genes 0.000 abstract 1
- 108090001030 Lipoproteins Proteins 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 abstract 1
- 101100481584 Mus musculus Tlr1 gene Proteins 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 abstract 1
- -1 diprovocim compound Chemical class 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 239000000568 immunological adjuvant Substances 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662356314P | 2016-06-29 | 2016-06-29 | |
| PCT/US2017/040028 WO2018005812A1 (en) | 2016-06-29 | 2017-06-29 | Diprovocims: a new and potent class of tlr agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018077397A2 true BR112018077397A2 (pt) | 2019-10-01 |
Family
ID=60787607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018077397A BR112018077397A2 (pt) | 2016-06-29 | 2017-06-29 | diprovocims: uma classe de agonistas de tlr |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11040959B2 (https=) |
| EP (1) | EP3445758B1 (https=) |
| JP (1) | JP6964298B2 (https=) |
| KR (1) | KR102522730B1 (https=) |
| CN (1) | CN109641878B (https=) |
| AU (1) | AU2017290238B2 (https=) |
| BR (1) | BR112018077397A2 (https=) |
| CA (1) | CA3026178C (https=) |
| IL (1) | IL263388B (https=) |
| WO (1) | WO2018005812A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113164445A (zh) * | 2018-08-02 | 2021-07-23 | 得克萨斯系统大学评议会 | Tlr1/2激动剂地普罗考姆的佐剂作用协同增效检查点抑制性抗体以消除疾病 |
| JP2023527792A (ja) | 2020-05-27 | 2023-06-30 | アキシャル セラピューティクス，インク． | Ｔｌｒ２調節剤化合物、医薬組成物、及びそれらの使用 |
| US20250367166A1 (en) * | 2022-04-29 | 2025-12-04 | The Scripps Research Institute | Next generation diprovocims that activate the innate and adaptive immune response |
| US20260091126A1 (en) * | 2022-09-20 | 2026-04-02 | The Curators Of The University Of Missouri | Amino acid-modified lipids for rna delivery |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1418905T3 (da) | 2001-08-08 | 2007-09-10 | Pentraxin Therapeutics Ltd | Terapeutisk middel til depletering af en uönsket proteinpopulation fra plasma |
| WO2005016235A2 (en) * | 2003-04-14 | 2005-02-24 | The Regents Of The University Of California | Combined use of impdh inhibitors with toll-like receptor agonists |
| PE20071079A1 (es) | 2005-11-15 | 2007-12-16 | Cytokinetics Inc | Compuestos de piperidina como inhibidores de la proliferacion celular |
| AU2011232421B2 (en) | 2010-03-23 | 2015-08-13 | Novartis Ag | Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| EP2958889B1 (en) | 2013-02-25 | 2017-03-22 | The Scripps Research Institute | Neoseptins: small molecule adjuvants |
| US9918959B2 (en) | 2014-08-06 | 2018-03-20 | The Board Of Regents Of The University Of Texas System | TLR-independent small molecule adjuvants |
-
2017
- 2017-06-29 KR KR1020197002820A patent/KR102522730B1/ko active Active
- 2017-06-29 BR BR112018077397A patent/BR112018077397A2/pt unknown
- 2017-06-29 EP EP17821259.3A patent/EP3445758B1/en active Active
- 2017-06-29 CN CN201780040830.9A patent/CN109641878B/zh active Active
- 2017-06-29 CA CA3026178A patent/CA3026178C/en active Active
- 2017-06-29 WO PCT/US2017/040028 patent/WO2018005812A1/en not_active Ceased
- 2017-06-29 JP JP2018568338A patent/JP6964298B2/ja active Active
- 2017-06-29 US US16/303,043 patent/US11040959B2/en active Active
- 2017-06-29 AU AU2017290238A patent/AU2017290238B2/en active Active
-
2018
- 2018-11-29 IL IL263388A patent/IL263388B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CN109641878B (zh) | 2021-09-14 |
| CA3026178C (en) | 2024-05-21 |
| WO2018005812A1 (en) | 2018-01-04 |
| KR20190014133A (ko) | 2019-02-11 |
| CA3026178A1 (en) | 2018-01-04 |
| IL263388A (en) | 2018-12-31 |
| JP6964298B2 (ja) | 2021-11-10 |
| EP3445758A1 (en) | 2019-02-27 |
| US11040959B2 (en) | 2021-06-22 |
| AU2017290238B2 (en) | 2021-02-18 |
| EP3445758A4 (en) | 2019-09-25 |
| KR102522730B1 (ko) | 2023-04-19 |
| AU2017290238A1 (en) | 2018-12-13 |
| CN109641878A (zh) | 2019-04-16 |
| JP2019519574A (ja) | 2019-07-11 |
| IL263388B (en) | 2021-02-28 |
| EP3445758B1 (en) | 2020-11-04 |
| US20200207742A1 (en) | 2020-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018077397A2 (pt) | diprovocims: uma classe de agonistas de tlr | |
| CR20180503A (es) | Composiciones y métodos para programar células terapéuticas utilizando nanoportadores de ácidos nucleicos dirigidos | |
| BR112014018679A2 (pt) | variantes de albumina | |
| MX382161B (es) | Una composicion plastificante que comprende di (2-etilhexil) tereftalato. | |
| BR112018000497A2 (pt) | processo para preparação de um composto | |
| BR112013022397A2 (pt) | vacinas combinadas com doses menores de antígeno e/ou adjuvante | |
| BR112015019817A2 (pt) | interface de vedação para um compartimento de telecomunicações | |
| BR112015028152A2 (pt) | inibidores de acc e usos dos mesmos | |
| BR112018075947A2 (pt) | composições de revestimento | |
| BR112017018305A2 (pt) | desacetoxitubulisina h e análogos da mesma | |
| BR112017028194A2 (pt) | moduladores de diaciglicerol aciltransferase 2 (dgat2) | |
| BR112015017572A2 (pt) | emulsão aquosa, uso da emulsão, método de fabricação da emulsão, método para operar um tomógrafo e método para detectar um composto semifluorado | |
| BR112017012062A2 (pt) | composição de revestimento aquosa e processo de preparar a mesma | |
| BR112017008176A2 (pt) | método de preparação do carbonato de ácido glicérico. | |
| BR112018010271A2 (pt) | material cristalino sintético emm-28, sua preparação e uso | |
| CR20150390A (es) | Inhibidores de la yodoproteina basada en 2,3-dihidroimidazol[1,2-c]pirimidin-5(1-h)-ona-asociada a la fosfolipasa a2 (lp-pla2) | |
| BR112013014715B8 (pt) | processo para produzir um artigo oco polimérico | |
| BR112018073690A2 (pt) | formulação contendo agonista de tlr e métodos de uso | |
| UY37016A (es) | Inhibidores de la tirosina quinasa de bruton y métodos de su uso | |
| MX2016013299A (es) | Composiciones de vacuna. | |
| BR112016028639A2 (pt) | composição de tintura de cabelo | |
| BR112015021133A2 (pt) | mistura de compostos, processo para produzir uma mistura de compostos e limpar superfícies duras ou fibras, formulação aquosa, e, uso de misturas de compostos | |
| BR112015028887A2 (pt) | métodos para preparação de um poliéster | |
| BR112013017520A2 (pt) | composto bicíclico ou sal do mesmo | |
| BR112017002560A2 (pt) | primer para fitas adesivas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |